$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Weekly Investment Analysts Ratings Changes for Bayer Aktiengesellschaft (BAYRY)
06:06am, Monday, 15'th Nov 2021 Transcript Daily
Several brokerages have updated their recommendations and price targets on shares of Bayer Aktiengesellschaft (OTCMKTS: BAYRY) in the last few weeks: 11/10/2021 Bayer Aktiengesellschaft had its overweight rating reaffirmed by analysts at JPMorgan Chase & Co.. 11/10/2021 Bayer Aktiengesellschaft had its overweight rating reaffirmed by analysts at Morgan Stanley. 11/10/2021 Bayer Aktiengesellschaft []
Pneumonia Therapeutics Market Insights and Development Trends 2021-2029: Abbott Laboratories, Allergan, AstraZeneca, Bayer
04:23am, Monday, 15'th Nov 2021 OpenPR
Pneumonia Therapeutics Market Snapshot: The global pneumonia therapeutics market was valued at USD 1700 million in 2019 and is expected to grow at 7.8% CAGR during the forecast period. Pneumonia is a prevalent form of an acute respiratory infection that affects the
ESSA Pharma: Why I Remain Bullish
05:00pm, Wednesday, 10'th Nov 2021
ESSA Pharma: Why I Remain Bullish
Bayer - Cheap Again, Plenty Of Volatility, But Still A 'Buy'
09:19am, Wednesday, 10'th Nov 2021
Investing in Bayer isn't for the faint-hearted given the company's recent and likely future valuation and earnings volatility. However, beneath the hood there's a qualitative company with superb funda
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2021 Results - Earnings Call Transcript
01:57pm, Tuesday, 09'th Nov 2021
Bayer Aktiengesellschaft (BAYZF) CEO Werner Baumann on Q3 2021 Results - Earnings Call Transcript
Bayer's (BAYRY) Q3 Earnings Beat Estimates, Revenues Rise Y/Y
11:28am, Tuesday, 09'th Nov 2021
Bayer's (BAYRY) earnings in the third quarter of 2021 beat estimates. Revenues surge year over year.
Bayer swings to a profit as sales rise and adjusts outlook
02:13am, Tuesday, 09'th Nov 2021
German pharmaceutical-and-chemical conglomerate Bayer AG on Tuesday swung to a profit for the third quarter and said sales rose, driven by a recovery in its agriculture business.
Bayer says head of agriculture unit quits
02:03am, Tuesday, 09'th Nov 2021
Bayer said on Tuesday the head of its crop science unit, Liam Condon, would quit at the end of the year to pursue other career opportunities, following disappointing results earlier this year.
U.S. farm co-op CHS to pay members to enroll in Bayer carbon farming program
06:17am, Wednesday, 03'rd Nov 2021
Agricultural seeds and chemicals supplier Bayer AG is expanding its carbon farming program to members of U.S. farm cooperative CHS Inc, boosting incentives for members to participate in the program, t
Reducing fertilizer emissions presents 'enormous opportunity,' Bayer says
05:08am, Tuesday, 02'nd Nov 2021
Bayer SVP Public Affairs & Sustainability Matthias Berninger discusses fertilizer emissions as a contributor to global greenhouse gases and the impact of rising temperatures on the global agricultural
Bayer sees no guidance hit from hurricane, planting trends
09:39am, Tuesday, 19'th Oct 2021
Bayer sees no impact on its full-year guidance from customers' changing planting habits or a five-week shutdown at its main glyphosate production site in Louisiana after Hurricane Ida, the German life
Bayer blasts 'unscientific' rejection by Mexican regulator of GMO corn permit
04:43pm, Friday, 08'th Oct 2021
Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement
Corteva faces slow start as it takes aim at Bayer's Brazil soy reign
07:05am, Friday, 08'th Oct 2021
U.S. pesticide and seed maker Corteva Inc will take up to three times longer to break into Brazil's genetically modified soy seed market than it did in the United States, where Corteva's sales grew ra
Bayer shares up after first trial win over Roundup
01:52am, Wednesday, 06'th Oct 2021
Shares in Bayer AG rose 2.5% in pre-market trade on Wednesday after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer.
Bayer wins its first Roundup jury verdict in case of child's cancer
07:09pm, Tuesday, 05'th Oct 2021
Bayer AG won its first trial over claims its Roundup weedkiller causes cancer after a California jury found that the herbicide was not a substantial cause of a child's rare form of non-Hodgkin's lymph
Sign In
Buy BAYRY